Diplopia

Schieken, Richard M.; Anderson, Warren T.; Anthony, Courtney L.

doi:10.1001/archpedi.1973.04160040084017

Cited by 4 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diplopia has previously been described as a rare, benign, transient manifestation of chorea, 2,14 and it was en countered in one of the eight patients in this study. The suggested mechanism for this ocular manifestation is dependent upon hemichorea in which intermittent choreiform movements of one eye prevent fusion of the images, 14 but true paralysis of extraocular muscles is very rare. Behavioural problems and neurological sequelae of Sydenham's chorea have been assessed in detail by other investigators 1,15,16 …”

Section: Discussionmentioning

confidence: 48%

Sydenham's Chorea: A New Look at an Old Disease

Al‐Eissa

1993

Int J Clinical Practice

View full text Add to dashboard Cite

SUMMARYEight children with Sydenham's chorea were studied to illustrate the clinical characteristics and the outcome of the disease. Their ages ranged from 8 to 13 years and the male to female ratio was 1.7:1. Most of them had hemichorea, which frequently affected the right side of the body. The common presenting manifestations were involuntary movements, facial grimacing, clumsiness, and emotional instability. The duration of chorea ranged from one week to three years, with a median of 11 weeks. One half of the patients had associated mild carditis. Recurrences of chorea occurred only among patients who were not maintained on continuous penicillin prophylaxis. Haloperidol seemed to be an effective and tolerable agent in controlling the motor manifestations of the disease.

show abstract

Section: Discussionmentioning

confidence: 48%

Sydenham's Chorea: A New Look at an Old Disease

Al‐Eissa

1993

Int J Clinical Practice

View full text Add to dashboard Cite

show abstract

“…The rest of the articles were manually screened by the authors in order to meet the eligibility criteria. In the end, a total of 26 articles remained: five were retrospective studies [ 21 , 22 , 23 , 24 , 25 ], three were prospective studies [ 26 , 27 , 28 ], nine were case reports [ 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ], six were case series [ 38 , 39 , 40 , 41 , 42 , 43 ], and three were observational cross-sectional studies [ 44 , 45 , 46 ]. Table 2 shows detailed information about the included studies on diplopia in other movement disorders (besides Parkinson’s disease).…”

Section: Resultsmentioning

confidence: 99%

“…Diplopia as an ocular manifestation in chorea was reported in a single study published in 1972 by Schieken R. et al who described two cases of children who developed diplopia in the context of acute rheumatic fever [ 41 ].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Diplopia in Movement Disorders: A Systematic Review of the Literature

Ungureanu,

Irincu,

Diaconu

et al. 2024

JPM

View full text Add to dashboard Cite

Introduction: Although the reported frequency of diplopia is between 10 to 40% of patients with Parkinson’s disease (PD) and other movement disorders, it remains one of the most undiagnosed non-motor symptoms. Furthermore, it has a major impact on the quality of life of these patients. The aim of this study is to systematically review the literature regarding the frequency, causes, and implications of diplopia in movement disorders. Methodology: An electronic search was conducted in March and June 2023 using the PubMed database in order to identify appropriate studies. Studies that were written in English, that represented observational, analytical studies, and case reports, and that provided information regarding diplopia in movement disorders were included in the systematic review. Results: A total of 686 articles were identified out of which 43 met the inclusion criteria. The studies included in the systematic review ranged from descriptive studies (case reports and case series) to analytical–observational studies (cross-sectional studies, prospective and retrospective cohort studies, and case–control studies). In Parkinson’s disease, the incidence of diplopia ranged from 10 to 38%. In these patients, diplopia was linked to the presence of visual hallucinations and cognitive decline but also to convergence insufficiency and the presence of motor fluctuations. Cases of diplopia secondary to deep brain stimulation were also reported. Diplopia was associated with longer disease duration and worse motor and non-motor scores. Diplopia was also reported in other movement disorders such as multiple system atrophy (frequency as high as 18%) and progressive supranuclear palsy (frequency as high as 39%) and was associated with increased mortality and shorter duration in life span. Conclusions: Diplopia occurs in up to 38% of patients with movement disorders and has a negative impact on their health-related quality of life. Treating physicians should actively ask about diplopia and other ophthalmological symptoms, as many patients do not spontaneously report them. The pathophysiology of diplopia is complex, and it involves heterogeneous peripheral and central mechanisms. The management of these patients should involve a multidisciplinary team of health professionals in order to provide appropriate, tailored management.

show abstract

Opsoclonus Associated With an Intracranial Tumor

Keane¹

1974

Arch Ophthalmol

View full text Add to dashboard Cite

Diplopia

Cited by 4 publications

References 4 publications

Sydenham's Chorea: A New Look at an Old Disease

Sydenham's Chorea: A New Look at an Old Disease

Diplopia in Movement Disorders: A Systematic Review of the Literature

Opsoclonus Associated With an Intracranial Tumor

Contact Info

Product

Resources

About